Literature DB >> 12112671

Anti-idiotypic protein domains selected from protein A-based affibody libraries.

Malin Eklund1, Lars Axelsson, Mathias Uhlén, Per-Ake Nygren.   

Abstract

Three pairs of small protein domains showing binding behavior in analogy with anti-idiotypic antibodies have been selected using phage display technology. From an affibody protein library constructed by combinatorial variegation of the Fc binding surface of the 58 residue staphylococcal protein A (SPA)-derived domain Z, affibody variants have been selected to the parental SPA scaffold and to two earlier identified SPA-derived affibodies. One selected affibody (Z(SPA-1)) was shown to recognize each of the five domains of wild-type SPA with dissociation constants (K(D)) in the micromolar range. The binding of the Z(SPA-1) affibody to its parental structure was shown to involve the Fc binding site of SPA, while the Fab-binding site was not involved. Similarly, affibodies showing anti-idiotypic binding characteristics were also obtained when affibodies previously selected for binding to Taq DNA polymerase and human IgA, respectively, were used as targets for selections. The potential applications for these types of affinity pairs were exemplified by one-step protein recovery using affinity chromatography employing the specific interactions between the respective protein pair members. These experiments included the purification of the Z(SPA-1) affibody from a total Escherichia coli cell lysate using protein A-Sepharose, suggesting that this protein A/antiprotein A affinity pair could provide a basis for novel affinity gene fusion systems. The use of this type of small, robust, and easily expressed anti-idiotypic affibody pair for affinity technology applications, including self-assembled protein networks, is discussed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112671     DOI: 10.1002/prot.10169

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  12 in total

1.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  An affibody in complex with a target protein: structure and coupled folding.

Authors:  Elisabet Wahlberg; Christofer Lendel; Magnus Helgstrand; Peter Allard; Vildan Dincbas-Renqvist; Anders Hedqvist; Helena Berglund; Per-Ake Nygren; Torleif Härd
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

3.  NMR assignments of the free and bound-state protein components of an anti-idiotypic affibody complex.

Authors:  Jakob Dogan; Christofer Lendel; Torleif Härd
Journal:  J Biomol NMR       Date:  2006       Impact factor: 2.835

4.  Electrophilic affibodies forming covalent bonds to protein targets.

Authors:  Lotta Holm; Paul Moody; Mark Howarth
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

5.  Surface Display of Small Affinity Proteins on Synechocystis sp. Strain PCC 6803 Mediated by Fusion to the Major Type IV Pilin PilA1.

Authors:  Ivana Cengic; Mathias Uhlén; Elton P Hudson
Journal:  J Bacteriol       Date:  2018-07-25       Impact factor: 3.490

6.  A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.

Authors:  Daniel R Woldring; Patrick V Holec; Lawrence A Stern; Yang Du; Benjamin J Hackel
Journal:  Biochemistry       Date:  2017-03-09       Impact factor: 3.162

7.  Biophysical characterization of Z(SPA-1)--a phage-display selected binder to protein A.

Authors:  Christofer Lendel; Vildan Dincbas-Renqvist; Alexander Flores; Elisabet Wahlberg; Jakob Dogan; Per-Ake Nygren; Torleif Härd
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

Review 8.  Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer.

Authors:  Eden R Padayachee; Fleury Augustin Nsole Biteghe; Zaria Malindi; Dirk Bauerschlag; Stefan Barth
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

9.  1H, 13C and 15N resonance assignments of an affibody-target complex.

Authors:  Christofer Lendel; Elisabet Wahlberg; Helena Berglund; Malin Eklund; Per-Ake Nygren; Torleif Härd
Journal:  J Biomol NMR       Date:  2002-11       Impact factor: 2.835

10.  Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy.

Authors:  Li Ding; Caiping Tian; Song Feng; Guissi Fida; Congying Zhang; Yuxiang Ma; Guanhua Ai; Samuel Achilefu; Yueqing Gu
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.